Flavin mononucleotide adenylyltransferase (FMNAT) catalyzes the formation of the essential flavocoenzyme flavin adenine dinucleotide (FAD) and plays an important role in flavocoenzyme homeostasis regulation. By sequence comparison, bacterial and eukaryotic FMNAT enzymes belong to two different protein superfamilies and apparently utilize different sets of active-site residues to accomplish the same chemistry. Here we report the first structural characterization of a eukaryotic FMNAT from the pathogenic yeast Candida glabrata. Four crystal structures of C. glabrata FMNAT in different complexed forms were determined at 1.20-1.95 Å resolutions, capturing the enzyme active-site states prior to and after catalysis. These structures reveal a novel flavin-binding mode and a unique enzyme-bound FAD conformation. Comparison of the bacterial and eukaryotic FMNATs provides a structural basis for understanding the convergent evolution of the same FMNAT activity from different protein ancestors. Structure-based investigation of the kinetic properties of FMNAT should offer insights into the regulatory mechanisms of FAD homeostasis by FMNAT in eukaryotic organisms.
Introduction
Flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) are essential cofactors that are involved in many redox reactions in the cell. 1 The chemical and functional versatility of these cofactors, in association with various flavoproteins, allows them to be involved in a large variety of reaction types and to participate in many cellular processes ranging from energy production, light emission, DNA repair, chromatin remodeling, and protein folding to detoxification, neural development, and apoptosis. [2] [3] [4] Riboflavin, also known as vitamin B2, is the universal precursor for the synthesis of FMN and FAD, the primary form of flavins in cells. 5, 6 Due to the involvement of flavocofactors in wide-ranging metabolic processes, riboflavin deficiency leads to a multitude of physiological aberrations such as abnormal fetal development, inadequate ion absorption, cardiovascular disease, and corneal defects. 7 In prokaryotes, yeast, and plants, riboflavin is either synthesized de novo or obtained from the environment and transported into cells. 6, 8 Higher eukaryotes, such as humans, lack the de novo riboflavin synthesis machinery, and their only means of obtaining riboflavin is through the diet. 5, 6 The riboflavin transporter for eukaryotes has been identified in Saccharomyces cerevisiae and is encoded by the gene mch5. 9 Converting riboflavin into FAD involves two universally conserved enzymes: riboflavin kinase (RFK) and flavin mononucleotide adenylyltransferase (FMNAT) (Fig. 1) . RFK (ATP: riboflavin 5′-phosphotransferase; EC 2.7.1.26) phos-phorylates riboflavin to generate FMN, while FMNAT (ATP:FMN adenylyltransferase; EC 2.7.7.2) adenylates FMN to form FAD. In bacteria, RFK and FMNAT are encoded in the same gene (ribF or ribC), 10, 11 and the protein product is referred to as flavin adenine dinucleotide synthetase (FADS), with the FMNAT domain located at the N-terminus and the RFK domain at the C-terminus. In eukaryotes, RFK and FMNAT are encoded by separate genes. 12, 13 In higher eukaryotes, the gene encoding FMNAT also contains a second domain with sequence similarity to proteins involved in molybdenum cofactor biosynthesis such as MogA and MoeA. 14, 15 The potential function of this molybdenum-cofactor-binding protein-like domain is unknown.
Bacterial and eukaryotic RFKs are similar in sequence and structure, and they belong to a unique protein family containing only RFKs. 16, 17 In contrast, the evolutionary link between bacterial and eukaryotic FMNATs is less clear, as they show little sequence similarity and are classified in different protein superfamilies in SCOP 18 or in different clans in Pfam 19 databases. The bacterial FMNAT domain of the bifunctional RFK/FMNAT belongs to the (H/T)xGH motif-containing nucleotidylyl transferase superfamily, while eukaryotic FMNAT is currently classified as a member of the 3′-phosphoadenosine 5′-phosphosulfate (PAPS) reductase-like family belonging to the "adenine nucleotide α-hydrolase-like" superfamily, which has conserved motifs different from those of nucleotidylyl transferases. Despite substantial differences in sequence and structure, mammalian and bacterial FMNAT enzymes have similar kinetic properties. 20, 21 Both enzymes catalyze the formation of FAD through an ordered bi-bi mechanism and have the same substrate binding and product release order, where ATP binds first to the enzyme followed by FMN, and product inorganic pyrophosphate (PP i ) is released first followed by FAD release. Pronounced product feedback inhibition was observed for rat liver FMNAT, and it was suggested that such a property would enable FMNAT to play a role in regulating cellular FAD homeostasis as the K i values of FAD against FMN (0.75 μM) and Mg 2+ -ATP (1.3 μM) are close to the concentration of free FAD (0.4 μM). 21 Maintenance of FAD homeostasis is important, as several cellular processes, such as oxidative protein folding and homocysteine metabolism, are sensitive to FAD levels. 22, 23 Both RFK and FMNAT are needed to generate the indispensable flavocofactors FMN and FAD. 6 The essentiality of the two enzymes has been established experimentally in bacterial 24 and yeast species, 12, 13, 22 and has been inferred to all other organisms. The significant differences between eukaryotic and bacterial FMNATs make them particularly attractive targets for developing selective anti-infectious drugs. 24 Structural analysis of both eukaryotic and bacterial FMNATs will reveal the different configurations of the substrate-binding and catalytic sites, which may benefit structurebased inhibitor development efforts. Such analysis will also address two fundamental questions: how eukaryotic and bacterial FMNAT accomplish the same chemistry with different active-site architectures, and what mechanistic controls are embedded in the enzyme to influence FAD homeostasis. Here we report the first structural characterization of a eukaryotic FMNAT from Candida glabrata, an opportunistic yeast pathogen that causes candidemia and invasive candidiasis. 25, 26 We have determined the crystal structures of C. glabrata FMNAT (CgFMNAT) in the apo form and in three different complexed forms [with ATP, with substrate FMN and the ATP analog α,β-methyleneadenosine 5′-triphosphate (AMPCPP), and with products FAD and PP i , respectively]. These structures reveal a novel flavin-binding mode and a detailed catalytic site configuration that are likely shared among all eukaryotic FMNATs. Combined with results from a steady-state kinetic analysis, a mechanism for eukaryotic FMNAT-catalyzed adenylyl transfer reaction is proposed.
Results

Quality of structures
The crystal structure of apo-CgFMNAT was solved by the single-wavelength anomalous dispersion (SAD) phasing method using selenomethionine as the source of anomalous dispersion and was refined against a native data set to a resolution of 1.20 Å (Table 1 ). There is one CgFMNAT molecule in the asymmetric unit. Crystal-packing analysis suggests that the functional unit of CgFMNAT is a monomer, consistent with the gel-filtration result showing that CgFMNAT is monomeric in solution (see Fig. S1 , available online). The refined model contains residues −3 to 304, except for residues 85-101, for which we found no associated electron density and which are presumably disordered. Residues − 3 to 0 (GlyAla-Met-Val) were introduced during cloning (see Supplementary Methods). The CgFMNAT-ATP complex crystal is isomorphous to apo-CgFMNAT, 
where 〈I〉 is the average of all j measurements of reflection hkl. c Six anisotropic thermal factors were used for selected atoms, while isotropic B-factors were used for the remaining atoms. Anisotropic thermal parameters were evaluated and assigned using PARVATI 27 and ANISOANL.
where F o and F c are the observed and calculated structure factors, respectively. e R-factor calculated from randomly selected 1.5% (apo-CgFMNAT) or 5% (complexes) reflections that are excluded from refinement for cross-validation. and its model was refined to 1.87 Å resolution. This model contains residues − 3 to 83, residues 103-304, and an ATP molecule with well-defined density (Fig. 2a) . Crystals of the substrate and product ternary complexes are isomorphous to each other and belong to the space group C2, with six monomers in the asymmetric unit. They were refined to resolutions of 1.95 Å and 1.35 Å, respectively. For the substrate ternary complex, the densities for AMPCPP and Mg 2+ are well defined, and double conformations of the AMPCPP phosphate tail are observed (Fig. 2b) . The density for the phosphoribityl tail of FMN, on the other hand, is discontinuous, indicating significant conformational flexibility (Fig. 2b) . For the product ternary complex, the densities for both products FAD and pyrophosphate (PP i ) are well defined (Fig. 2c) . The flexible loop region (residues 84-100) disordered in the apo and ATP-complexed CgFMNAT structures is ordered in two of the six crystallographically independent CgFMNAT monomers in the ternary complexes, presumably due to crystal-packing interactions. For all models, the main-chain dihedral angles (ϕ,ψ) for each residue are within the allowed regions of Ramachandran plot. The exception is Gly224 in the ATP complex structure, which is associated with well-defined electron density. Superposition of the C α backbones of the apo protein, ATP complex, and substrate ternary complex (monomer C) to the product ternary complex (monomer B) gives root mean square deviation (rmsd) values of 0.42 Å, 0.41 Å, and 0.27 Å, respectively, indicating no substantial conformational changes among these structures (Fig. 2d ).
Overall structure
CgFMNAT is composed of two domains (Fig. 3a) . The N-terminal domain has an α/β fold with a central twisted six-stranded β-sheet sandwiched by α-helices. The topology of this domain is a modified Rossmann fold where the fifth β-strand of the central β-sheet is anti-parallel with the rest of the strands (Fig. 3a) . Comparison of CgFMNAT with known protein structures using the Dali server 29 indicates that the core of CgFMNAT is most similar to the members of the PAPS reductase-like protein family. These include bacterial adenosine 5′-phosphosulfate (APS) reductase 30 (1zun; Z-score of 13.1 and rmsd of 2.9 Å for 160 superimposed C α atoms). Similar to CgFMNAT, these proteins also have an N-terminal domain of a modified Rossmann-fold topology (Fig. 3b) . The Cterminal domain of CgFMNAT is composed largely of loops (64%) interlaced by α6-α9 helices and two short 3 10 -helices (Fig. 3a) . This domain is much longer than those of APS and PAPS reductases and appears to be uniquely elaborated and expanded in yeast FMNAT (Supplementary Fig. S2 ). As will be discussed later, residues from this domain are also involved in interactions with ATP.
Mg
2+ -ATP binding site
The structures of the CgFMNAT-ATP binary complex and the substrate ternary complex reveal details about the interactions between the enzyme and the ATP substrate. Five structural motifs are identified to be involved in ATP and Mg 2+ binding (Fig. 3a) . The PP-loop motif, extending from β1 to the N-terminus of α3, has the sequence of 60 SYNGGKDC 67 and is generally conserved in the superfamily. The ADE motif, named for ADEnine binding, corresponds to the LDTG motif in APS reductase 30 and consists of a short stretch of four residues ( 107 FIDH 110 ) following strand β2. The first arginine-containing ARG1 motif (named Arg-loop in Chartron et al. 30 ) is located in the loop connecting β4 to β5 and consists of residues 163 GIRHTD 168 . The γ-phosphate motif encompasses part of α7 and the following hairpin loop from the C-terminal domain situated above the nucleotide binding site. Near the C-terminus of the protein, another arginine-rich motif, ARG2, of sequence 296 ERAGR 300 is also involved in nucleotide binding.
The ATP nucleotide binds in a crevice formed between β1 and β4, with its βγ-phosphate tail positioned in an anion-binding pocket near the N-terminus of α3 (Fig. 4a) . A hydrogen bond network is formed between ATP and residues from the five motifs (Fig. 4a) . The adenine N1 nitrogen and N6 amino groups are hydrogen bonded to the mainchain amide and carbonyl of Ile108 (part of the ADE motif), respectively. The N3 group of adenine forms a hydrogen bond with the side chain of Ser60 of the PP-loop motif, while the O2′ hydroxyl of ATP ribose interacts with the main-chain carbonyl of Ser60. The O2′ hydroxyl forms another hydrogen bond with the main-chain amide of Gly163 of the ARG1 motif. The PP-loop motif residues interact extensively with the phosphates of ATP through both main-chain and side-chain moieties. The side chain of Asn62 interacts with the α-phosphate; the main-chain amide of Cys67 interacts with the β-phosphate; and the side chain of Lys65 provides two hydrogen bonds to the γ-phosphate. Additional hydrogen bonds to the γ-phosphate are formed with the Tyr216 hydroxyl and the Leu223 main-chain amide. Both residues are from the γ-phosphate motif (Fig. 4a) .
In the presence of magnesium ions, as in the case of the substrate ternary complex structure, the AMPCPP phosphate tail adopts two distinct conformations (conformers I and II; Figs. 2b and 5) in different monomers of the six CgFMNAT substrate ternary complexes in the asymmetric unit, both of which differ from that observed in the Mg 2+ -free ATP binary complex structure (Fig. 5 ). The largest difference between these conformations is in the position of the β-phosphate, which moves by 5.1 Å between conformers I and II, while the α-and γ-phosphates move by 1.6 Å and 2.2 Å, respectively. In both conformers, the bound Mg 2+ remains in the same position and maintains a six-ligand octahedral configuration (Fig. 5) . In the first conformer, Mg 2+ is liganded to the β-and γ-phosphate oxygens, the Asp66 side-chain carboxyl, and the three conserved water molecules w2, w3, and w4 (Fig. 4a ). W2 and w3 are further coordinated to the carboxylate group of Asp168 of the ARG1 motif. In the second conformer, all three AMPCPP phosphoryl moieties are coordinated to Mg 2+ , with the β-phosphate oxygen substituting for the w4 water ligand. The β-phosphate in this conformation also interacts with Arg279 of the ARG2 motif through a bifurcated hydrogen bond (data not shown). In the Mg 2+ -free ATP binary complex structure, the position of the β-phosphate largely overlaps with the Mg 2+ binding site (Fig. 5) .
Compared to other PAPS reductase-like proteins, three of the five ATP-binding motifs in the CgFMNAT, PP-loop, ADE, and ARG1 motifs are conserved (Fig. S2) . Although the γ-phosphate motif is also present in members of the PAPS reductase-like family such as APS reductase and bacterial ATP sulfurylase, its role in substrate binding and catalysis in these enzymes is not clear. Unique to CgFMNAT and APS reductase is the presence of the ARG2 motif ( Supplementary Fig. S2 ). In APS reductase, Arg242 and Arg245 near the protein C-terminus, corresponding to Arg297 and Arg300 of CgFMNAT, provide important interactions with the phosphosulfate group of APS. Our preliminary kinetic analysis of the R297A mutant shows that the apparent K m,ATP and K m,FMN values of the mutant increased by ∼ 5 and ∼ 3 times, respectively, compared to the wildtype enzyme (data not shown), indicating that this Arg residue is indeed involved in substrate binding, presumably through interactions with the phosphoryl groups of the substrates.
FMN/FAD binding site
Unexpectedly, the flavin binding site, as revealed in the substrate and product ternary complexes, is located on the same side of the central β-sheet as the adenosine moiety of ATP, where a deep trough is formed between the face of the β-sheet, helix α5, and the loop connecting the anti-parallel β5 to β6 (Figs. 3 and 4) . This pocket forms a unique binding site for the flavin isoalloxazine ring that is different from those observed in any other FMN-or FADbinding protein. 33 Residues from a broad range of structural elements are involved in the interaction with the isoalloxazine ring (Figs. 3a and 4c ). These include Met143 and Phe147 from helix α5, Ile160 and Ile162 from strand β4; Asp181, Trp184, and Phe187 from the loop connecting β5 to β6, and Arg189 from strand β6. These residues are highly conserved among eukaryotic FMNATs (Supplementary Fig. S3 ) and are collectively referred to as the flavin motif. The isoalloxazine ring is sandwiched between the indole ring of Trp184 and the planar guanidinium group of Arg189. Deeply buried in the flavin-binding pocket is the hydrophobic dimethylbenzene moiety of the isoalloxazine ring, forming van der Waals contacts with the hydrophobic side chains of Met143, Phe147, Ile160, Ile162, and Phe187 ( Fig. 4b and c) . The hydrophilic lumazine side of the ring forms two specific hydrogen bonds with the enzyme, between its C4 carbonyl and the main-chain amide of Asp181, and between its N3 amide and the side chain of Asp 181, respectively. In both substrate and product ternary complex structures, the isoalloxazine group is also in van der Waals contact with the adenosine moiety of either AMPCPP or FAD, suggesting that the adenosine group is part of the isoalloxazine-binding pocket.
In contrast to extensive interactions with the isoalloxazine ring, there are few contacts between the enzyme and the FMN phosphoribityl tail (Fig. 4b) . As a result, the conformation of this part of the substrate is not well defined, as indicated by high Bfactors, partial occupancy, and discontinuous density (Fig. 2b) . In five of the six monomers in the asymmetric unit, the FMN phosphoribityl tail is seen pointing toward the solvent, positioned over the N-terminus of helix α5 and away from the bound AMPCPP, probably due to electrostatic repulsion (Figs. 4b and 5 ). This observed conformation of FMN is apparently not in the catalytically ready state, as the phosphate is too far from the bound AMPCPP. Clearly, the flexibility of FMN phosphoribityl tail would allow it to adopt multiple conformations and to move close to ATP so that the adenylyltransferase reaction could occur. Comparing the substrate and product ternary complexes, the positions of the isoalloxazine ring and the adenosine moieties remain essentially unchanged (Fig. 5) . The phosphoribityl group of the product FAD becomes well ordered when covalently linked to the adenylyl group of ATP. The position of the PP i product is also well defined in the crystal structure and is identical with that of the βγ-phosphates of AMPCPP in conformer I. The Mg 2+ in the product ternary complex is coordinated to the PP i , the adenylyl phosphate of FAD, Asp66, and two water molecules in a configuration with features of both AMPCPP conformers in the substrate ternary complex (Fig. 5) . Arg297 from the C-terminal ARG2 motif is found to interact with the diphosphate moiety of FAD (Fig. 4c) , supporting its potential involvement in binding the phosphate groups of both ATP and FMN substrates and in positioning them for the adenylyl transfer reaction.
Steady-state kinetic properties of CgFMNAT
The steady-state kinetic parameters of CgFMNAT were determined using a continuous coupled assay. The Lineweaver-Burk reciprocal plots of 1/ν versus 1/[FMN] and 1/ν versus 1/[ATP] (Fig. 6a and b) are consistent with an ordered bi-bi system, 34 with the substrate-binding order being ATP first, followed by FMN. The same mechanism and substratebinding order were also proposed for rat liver and bacterial FMNATs in early studies. 20, 21 The initial rates of the reaction were globally fitted to the general equation for an ordered steady-state bireactant model (insets of Fig. 6a and b) 
Proposed mechanism for CgFMNAT
The four high-resolution structures of CgFMNAT (apo form, complexe with ATP, complexe with the substrate FMN + AMPCPP, and complexe with the product FAD + PP i ), along with kinetic data, allow us to envision events in the enzyme active site during catalysis ( Fig. 6c ; Supplementary Movie). In this process, ATP preferably binds first to the enzyme because its binding pocket would be partially blocked by FMN, which binds at a site closer to the surface (Fig. 7) . Additionally, binding ATP first may help to properly position the FMN substrate, as the C8M methyl group of the isoalloxazine ring is packed against the adenosine moiety of the bound ATP. These observations are consistent with the substrate-binding order deduced from the kinetic data. The binding of ATP induces a small adjustment (0.3-0.5 Å) of several surrounding residues, including Asn62, Lys65, Asp66, Ile108, and Asp168, presumably to optimize their interactions with Mg 2+ and ATP. In the presence of Mg 2+ , the phosphate tail of ATP can adopt either of the two discrete conformations I or II, in which the Mg 2+ position remains the same (Fig. 5) . Upon subsequent binding of FMN, side chains of several residues around the isoalloxazine ring (e.g., Met143, Phe147, Asp181, and Trp184) also make small adjustments to optimally interact with the substrate. Due to lack of interaction between the enzyme and the phosphoribityl tail of FMN, this part of the FMN substrate is highly flexible and able to adopt multiple conformations. For the adenylation reaction to occur, the FMN phosphate would move close to the α-phosphate of ATP for the ensuing nucleophilic attack. The presence of Mg 2+ and interaction with Arg297 (and potentially Arg300) of the ARG2 motif may help to overcome electrostatic repulsion between the phosphate groups of the two substrates and to position FMN phosphate for the attack on the α-phosphate of ATP (Fig. 6c) . The cleavage of the αβ-phosphodiester bond is facilitated by coordination of Mg 2+ , which is required for the reaction. The Mg 2+ -ATP in the conformer I position appears to be the catalytically competent conformation, which allows the FMN phosphate group to approach the α-phosphate from the direction opposite the β-phosphate for the direct in-line nucleophilic attack. Minimal structural rearrangements are observed after product formation. The leaving diphosphate group is practically in the same position as the βγ-phosphates of conformer I of the nucleotide and interacts with the same set of protein residues and Mg 2+ . The transferred α-phosphate moves by about 2.5 Å away from its original position and is now directly liganded to Mg 2+ ( Fig. 5; Supplementary Movie) . Earlier kinetic studies of rat liver FMNAT revealed that the enzyme is markedly inhibited by the product FAD with a K i of 0.75 μM against FMN and a K i of 1.3 μM against Mg 2+ -ATP. 21 It has been suggested that the biosynthesis of FAD is most likely regulated by the product FAD at the last FMNAT step of the pathway. 21 Although not yet determined explicitly, our observation that CgFMNAT copurifies with intrinsically bound FAD, along with extensive interactions between the enzyme and FAD seen in the crystal structure, suggests that FAD binds to CgFMNAT with high affinity and likely exerts a feedback inhibitory effect as well.
Discussion
Our high-resolution structures of yeast FMNAT present the first characterization of a eukaryotic version of this essential enzyme. Although the overall structure of CgFMNAT shares a significant similarity with the PAPS-reductase-like family of proteins, as reflected in several shared nucleotide-binding motifs, the mode of flavin binding in CgFMNAT has not been observed before. In a 2001 survey by Dym and Eisenberg, all FAD-binding proteins with known three-dimensional structures were categorized into four different groups, represented by glutathione reductase, ferredoxin reductase, p-cresol methylhydroxylase, and pyruvate oxidase. 33 CgFMNAT is clearly distinct from any of these FAD-binding proteins in both the conserved sequence motifs and the flavin-binding mode. In other Rossmann-fold FAD-binding proteins (e.g., glutathione reductase and pyruvate oxidase groups), the isoalloxazine ring of FAD invariably binds on the side of the central β-sheet opposite from the adenine moiety and across the top of the sheet between β1 and β4. It often interacts with residues from another domain. In contrast, in CgFMNAT, the isoalloxazine ring binds to the same side of the central β-sheet as the adenine, and the binding exclusively involves residues from the Rossmannlike N-terminal domain. The deviation from the typical Rossmann-fold topology, characterized by an anti-parallel strand β5 at the edge of the β-sheet, opens up the side of the β-sheet to form the flavinbinding pocket. In the CgFMNAT product ternary complex structure, FAD adopts a bent conformation with adenosine moiety and isoalloxazine ring pack against each other. While the FAD cofactor in most flavoproteins adopts an extended conformation, bent FAD has been observed in flavodoxin reductase and DNA photolyase. 33 Yet, the conformations of these bent FADs are very different from that in CgFMNAT (Fig. 8) , further emphasizing the unique flavin-binding mode of eukaryotic FMNAT.
A comparison of the structures of CgFMNAT, a prototypical eukaryotic FMNAT, and bacterial FMNAT, as exemplified by Thermotoga maritima FADS (TmFADS), 39 revealed remarkable differences in substrate-binding modes and catalytic site configurations. TmFADS belongs to the large nucleotidylyl transferase superfamily, with the signature (H/T)xGH motif located between the end of the first β-strand and the first helix of the Rossmann-fold core. It has a conformation different from that of the corresponding PP-loop region of CgFMNAT (Fig. 9) . The second conserved motif of the nucleotidylyl transferase superfamily ISSTxxR is located at the Nterminal end of an α-helix in a C-terminal subdomain and interacts with the β-and γ-phosphates of the ATP nucleotide. No equivalent structural motif corresponding to the ISSTxxR motif exists in CgFMNAT, although the γ-phosphate motif appears to perform a similar role. Most strikingly, the bound adenine nucleotides in the two proteins are oriented in opposite directions with regard to the plane of the central β-sheet (Fig. 9) , delineating two completely different nucleotide-binding modes in these two protein superfamilies. Currently, no flavin-bound bacterial FMNAT structure is available. Based on the structural similarity of TmFADS to other members of nucleotidylyl transferases such as nicotinamide mononucleotide adenylyltransferases (NMNATs) for which extensive structural information is available, [40] [41] [42] the FMN substrate likely binds to a site corresponding to the nicotinamide mononucleotide binding site in NMNAT on the opposite side of the central β-sheet from ATP so that the product FAD adopts a largely extended conformation (Fig. 9,  right) . Again, this arrangement is very different from the flavin-binding mode observed in CgFMNAT (Fig. 9, left) . Thus, eukaryotic and bacterial FMNATs present a remarkable case of ancient Rossmann-fold proteins that, after first diverging into two distinct protein families with different nucleotide-binding modes, have developed the same enzymatic activity via different active-site configurations.
In summary, we present here high-resolution structures of a eukaryotic FMN adenylyltransferase in different complexed states, which revealed details about active-site configuration and a unique FADbinding mode. The extensive interactions observed between the enzyme and the product FAD, and the lack of conformational changes after catalysis may explain why the enzyme is likely inhibited by the product. These structures lay the foundation for future investigation of the functional roles of activesite residues and the mechanism by which FMNAT influences FAD homeostasis in cells. 39 and homologous NMNAT-NAD complex structures 40 . Corresponding structural elements are colored identically in the two structures. 
Materials and Methods
Protein expression and purification
The predicted gene encoding CgFMNAT (gi|50291750) was amplified from C. glabrata genomic DNA (strain NCYC; ATCC36909D) by PCR and cloned into the NcoI and SalI restriction sites of the pHIS parallel vector. 43 The plasmid was transformed into Escherichia coli BL21(DE3) (Novagen), and the His 6 -CgFMNAT protein was expressed at 20°C. His 6 -CgFMNAT was first loaded on a nickel-Sepharose affinity column (GE Healthcare) equilibrated in buffer A [20 mM Hepes (pH 8.0), 300 mM NaCl, 20 mM imidazole, 5% (vol/vol) glycerol, and 1 mM DTT] and eluted with a gradient of 20-500 mM imidazole in buffer A. The His 6 -tag was cleaved by tobacco etch virus protease during overnight dialysis at 4°C and was removed from CgFMNAT by passing through the nickelSepharose affinity column for a second time. As a second purification step, protein was loaded onto a Resource Q anion exchange column (GE Healthcare) equilibrated with buffer B [20 mM Hepes (pH 7.5) and 5% (vol/vol) glycerol] and eluted with a 0−350 mM NaCl gradient, which yielded two pools. The first pool was in bright yellow and was later shown to contain the CgFMNAT-FAD complex. The second pool was in light yellow, indicating the presence of flavin with partial occupancy. To remove the flavin and to obtain homogeneous apo-CgFMNAT, the second pool was incubated with 1.5 M (NH 4 ) 2 SO 4 and purified by phenylSepharose hydrophobic interaction chromatography (GE Healthcare). The final purification step for both CgFMNAT-FAD and apo-CgFMNAT consisted of a sizeexclusion chromatography column (Superdex 75 16/60; GE Healthcare), and the protein was eluted in 20 mM Hepes (pH 7.5), 150 mM NaCl, and 1 mM DTT. The selenomethionyl apo-CgFMNAT was expressed in E. coli BL21 (DE3) grown in minimal media supplemented with selenomethionine and other nutrients, and purified using the same procedure as for apo-CgFMNAT.
Crystallization
All crystals were grown using hanging-drop vapordiffusion methods. For apo-CgFMNAT and ATP complex crystallization, the reagents and greased 24-well plates were chilled on ice before setting up crystallization drops. The apo-CgFMNAT crystals were grown by mixing 1.5 μl of protein (24 mg/ml in the gel-filtration column buffer) with 1.5 μl of reservoir solution composed of 0.1 M Na acetate (pH 4.4-5.4) and 6-12% (wt/vol) polyethylene glycol 4000 and by equilibrating against the reservoir at 16°C. Prism-shaped apo-CgFMNAT crystals grew to a maximum size of 0.55 mm × 0.35 mm × 0.35 mm within several days. Selenomethionyl apo-CgFMNAT crystals were grown under similar conditions as the native protein.
The CgFMNAT-ATP complex crystals were grown in the presence of 10 mM ATP under similar conditions as those for apo-CgFMNAT. The cocrystals of the CgFMNAT substrate ternary complex were grown at 20°C in the presence of 0.2 mM FMN and 5 mM AMPCPP under similar conditions as those for apo-CgFMNAT, except that consecutive microseeding procedure was performed in order to obtain single crystals. The CgFMNAT product ternary complex was obtained by adding 2 mM Na pyrophosphate to the CgFMNAT-FAD pool (final protein concentration of ∼ 20 mg/ml in gel-filtration buffer). The complex crystals were grown by mixing 1.5 μl of the CgFMNAT- 4 , and 20-26% (wt/vol) polyethylene glycol MME 2000, and by equilibrating against the reservoir at 20°C. All crystals were cryoprotected in a solution containing all the reservoir components and increments of glucose (10%, 20%, and 30%), flash-frozen in liquid propane, and stored in liquid nitrogen. For cryoprotection of the substrate ternary complex crystals, 5 mM MgSO 4 was also added along with glucose.
Data collection, X-ray structure determination, and refinement
The 2.18-Å SAD data from a selenomethionyl apoCgFMNAT crystal was collected at the absorption edge (K-edge) of selenium at beamline 19-BM; the 1.20-Å native apo-CgFMNAT and the 1.35-Å CgFMNAT product ternary complex data sets were collected at beamline 19-ID of the Advance Photon Source, Argonne National Laboratory. The 1.87-Å data set for the ATP complex and the 1.95-Å data set for the substrate ternary complex were collected in-house with X-ray from a rotating anode generator (Rigaku FRE SuperBright) recorded on an R-AXIS IV ++ (Rigaku) image plate detector. All data were processed with either the HKL2000 package or the HKL3000 package. 44, 45 Data collection statistics are presented in Table 1 . The initial phases for apo-CgFMNAT were obtained by the SAD phasing method (see Supplementary Methods for details), while the phases of all complexes were determined by the molecular replacement method using the program MOLREP 46 and the refined apoCgFMNAT as search model. The refinements were performed using REFMAC 47 or PHENIX, 48 and manual model building was performed with Coot. 49 Models were assessed by MolProbity. 50 
Steady-state kinetics
Steady-state kinetic parameters were determined using a continuous coupled assay (EnzChek® pyrophosphate assay kit; Molecular Probes), with modifications. The reaction mixture (0.5 ml) contained 20 mM Hepes (pH 7.5), 2 mM MgCl 2 , 0.5 U of purine nucleoside phosphorylase, 0.015 U of inorganic pyrophosphatase, 0.2 mM 2-amino-6-mercapto-7-methylpurine riboside, 21 nM (10.5 pmol or 378 ng) apo-CgFMNAT, 2.5-20 μM FMN, and 1-250 μM ATP. All enzyme reactions were carried out in duplicate and performed at 25°C. The reaction was initiated by the addition of ATP, and progress was monitored at 360 nm for 5 min. Steady-state kinetic parameters were determined by fitting the initial rates to the general equation describing a bireactant ordered bi-bi system (Eq. (1) where K m,ATP and K m,FMN are the Michaelis-Menten constants, and K i,ATP is the dissociation constant for an ATP-enzyme complex. A nonlinear least-squares method, as implemented in the Sigma Plot Enzyme Kinetics module (Systat Software), was used to fit the data.
Accession codes
The coordinates and structures factors have been deposited in the PDB with accession codes 3FWK (apo-
